Scott Platshon is a highly acclaimed Bioengineering and Biomedical Engineering professional with extensive expertise in providing operational and strategic leadership to several organizations in the healthcare and biotech industry. He studied at Menlo School and Stanford University for Bachelor of Science (B.S.) in Bioengineering and Biomedical Engineering. Scott Platshon held various leadership roles including investor at EcoR1 Capital, LLC, Board Member at Ajax Therapeutics, Board Member at Kumquat Biosciences Inc., Chief Operating Officer at Panacea Acquisition Corporation I & II, Board Observer at PellePharm, Janux Therapeutics, and Ashvattha Therapeutics, Inc., and Board Member at Silverback Therapeutics. Before joining these organizations, he worked as a financial analyst for Aquilo Partners, L.P. Scott Platshon's exceptional expertise and leadership skills have played a crucial role in many companies' success and advancements in the industry.